What's New Related to Drugs
More Email Subscriptions Related to Drugs
RSS Feed for This Page
Updated Monday through Friday
December 29, 2021
- Questions and Answers: Integration of FDA Facility Evaluation and Inspection Program for Human Drugs (updated)
- Drug Shortages (12/28/2021)
- Amino Acids (Updated - Currently in Shortage)
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Cefazolin Injection (Updated - Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated - Currently in Shortage)
December 28, 2021
- Drugs@FDA Data Files (updated)
- Patent Certifications and Suitability Petitions (updated)
December 27, 2021
- CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19 - Bamlanivimab and Etesevimab CDER Review (154 KB)
- Drug Shortages
- Dexmedetomidine Injection (New - Currently in Shortage)
- Propofol Injectable Emulsion (Updated - Currently in Shortage)
- Triamcinolone Acetonide Injectable Suspension (Updated - Currently in Shortage)
- FDA Urges Manufacturers to Develop Solutions for iPLEDGE REMS Website
- Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers (updated)
- Timeline of Selected FDA Activities and Significant Events Addressing Opioid Misuse and Abuse (updated)
December 23, 2021
- FDA Drug Shortages
- Ambrisentan Tablets (New - Discontinuation)
December 22, 2021
- FDA approves add-on therapy to lower cholesterol among certain high-risk adults
- Generic Drugs Program Activities Report - Monthly Performance
- FDA Drug Shortages
- Dexmedetomidine Injection (Updated - Currently in Shortage)
- Rifampin Capsules (New - Currently in Shortage)
- Sodium Chloride Injection USP, 0.9% Vials and Syringes (New - Currently in Shortage)
- Vecuronium Bromide for Injection (Updated - Currently in Shortage)
- Manual of Policies and Procedures (MAPP) 5019.1 Rev.1 Allowable Excess Volume/Content in Injectable Drug and Biological Products
- Digital Health Technologies for Remote Data Acquisition in Clinical Investigations, Guidance for Industry
December 21, 2021
- Drugs@FDA Data Files (updated)
December 17, 2021
- FDA Drug Competition Action Plan (updated)
- FDA approves drug to treat sickle cell disease in patients aged 4 up to 11 years (new)
- FDA Drug Shortages
- Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage)
- Dexmedetomidine Injection (Updated - Currently in Shortage)
- Ketamine Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Midazolam Injection (Updated - Currently in Shortage)
- Vecuronium Bromide for Injection (Updated - Currently in Shortage)
- Curriculum Materials for Health Care Degree Programs | Biosimilars (new)
- CDER Conversation: CDER Creates New Biosimilars Resources for Educators, Teaching Facilities (new)
December 16, 2021
- FDA Drug Shortages
- Amitriptyline Hydrochloride Tablets (New - Discontinuation)
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Bacteriostatic 0.9% Sodium Chloride Injection (Updated - Currently in Shortage)
- Bupivacaine Hydrochloride and Epinephrine Injection (Updated - Currently in Shortage)
- Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Calcium Gluconate Injection (Updated - Currently in Shortage)
- Chloroprocaine Hydrochloride Injection (Updated - Currently in Shortage)
- Cytarabine Injection (Updated - Currently in Shortage)
- Dacarbazine Injection (Updated - Currently in Shortage)
- Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage)
- Dexmedetomidine Injection (Updated - Currently in Shortage)
- Disopyramide Phosphate (Norpace) Capsules (Updated - Currently in Shortage)
- Dobutamine Hydrochloride Injection (Updated - Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage)
- Furosemide Injection (Updated - Currently in Shortage)
- Gentamicin Sulfate Injection (Updated - Currently in Shortage)
- Hydromorphone Hydrochloride Injection (Updated - Currently in Shortage)
- Imipenem and Cilastatin for Injection (Updated - Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated - Currently in Shortage)
- Mannitol Injection (Updated - Currently in Shortage)
- Mepivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Midazolam Injection (Updated - Currently in Shortage)
- Misoprostol Tablets (Updated - Currently in Shortage)
- Morphine Sulfate Injection (Updated - Currently in Shortage)
- Ondansetron Hydrochloride Injection (Updated - Currently in Shortage)
- Pantoprazole Sodium for Injection (Updated - Currently in Shortage)
- Potassium Chloride Concentrate Injection (Updated - Currently in Shortage)
- Pramipexole Dihydrochloride Extended Release Tablets (New - Discontinuation)
- Protamine Sulfate Injection (Updated - Currently in Shortage)
- Rifampin Injection (Updated - Currently in Shortage)
- Ropivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Sodium Chloride Injection USP, 0.9% Vials and Syringes (Updated - Currently in Shortage)
- Sterile Water for Injection (Updated - Currently in Shortage)
- Sulfasalazine Tablets (Updated - Currently in Shortage)
- Inspection of Injectable Products for Visible Particulates, Guidance for Industry
December 15, 2021
- Competitive Generic Therapy Approvals (updated)
- FDA Drug Shortages
- Hydroxocobalamin Injection (Updated - Currently in Shortage)
- Lipid Injection (Updated - Currently in Shortage)
- Methylprednisolone Acetate Injection (New - Currently in Shortage)
- Fetal Pharmacology and Therapeutics October 21 - 22, 2021 (updated)
December 14, 2021
- Drugs@FDA Data Files (updated)
- Gilead Issues A Voluntary Nationwide Recall of Two Lots of Veklury (Remdesivir) Due to Presence of Glass Particulates
December 13 2021
- Pediatric Exclusivity Granted (updated)
December 10, 2021
- Pediatric Exclusivity Granted (updated)
- Orange Book
- Prescription to Over-the-Counter (OTC) Switch List (updated)
- FDA Drug Shortages
- Levoleucovorin Calcium Pentahydrate Injection (New - Discontinuation)
- Sodium Chloride 0.9% Injection Bags (New - Currently in Shortage)
- Triamcinolone Acetonide Injectable Suspension (Updated - Currently in Shortage)
- Tainted Sexual Enhancement Products
- How Modeling Was Used to Support the FDA Approval of a Topical Generic Drug Product
- Guidance for Industry
December 9, 2021
- FDA Drug Shortages
- Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Calcium Gluconate Injection (Updated - Currently in Shortage)
- Calcium Gluconate Injection (New - Currently in Shortage)
- Midazolam Injection (New - Currently in Shortage)
- Guidance for Industry:
- Chronic Rhinosinusitis with Nasal Polyps: Developing Drugs for Treatment
- Development of Anti-Infective Drug Products for the Pediatric Population
- CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports
- Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
- Manual of Policies and Procedures (MAPP) 4512.2 Rev.2 Conducting Effective Meetings in CDER: Remote Access Considerations
December 8, 2021
- FDA Drug Shortages
- Bacteriostatic 0.9% Sodium Chloride Injection (Updated - Currently in Shortage)
- Cytarabine Injection (Updated - Currently in Shortage)
- Sterile Water for Injection (New - Currently in Shortage)
- Sterile Water for Injection (Updated - Currently in Shortage)
- Triamcinolone Hexacetonide Injectable suspension (Updated - Currently in Shortage)
- Teligent Pharma, Inc.’s Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution USP 4% Due to Super Potency
December 7, 2021
- Drugs@FDA Data Files (updated)
- What's New in Regulatory Science (updated)
- Guidance for Industry:
December 6, 2021
- FDA Drug Shortages
- Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Parathyroid Hormone (Natpara) Injection (Updated - Currently in Shortage)
December 3, 2021
- Manual of Policies and Procedures (MAPP)
- 6050.1 Rev 2 Effect of Failure to Pay PDUFA Fees
- 6050.2 Effect of Failure to Pay BsUFA Fees
- FDA approves rituximab plus chemotherapy for pediatric cancer indications
- FDA approves pembrolizumab for adjuvant treatment of Stage IIB or IIC melanoma
December 2, 2021
- New In Vitro Methods to Understand and Mitigate Clinical Variability Associated with Injectable Suspensions
- FDA Drug Shortages
- Sodium Chloride Injection USP, 0.9% Vials and Syringes (Updated - Currently in Shortage)
- Sterile Water for Injection (New - Currently in Shortage)
December 1, 2021
- Good clinical practice collaboration with international regulators (updated)
- FDA approves pafolacianine for identifying malignant ovarian cancer lesions
- FDA approves Darzalex Faspro, Kyprolis, and Dexamethasone for Multiple Myeloma
- FDA Drug Shortages
- Amino Acids (Updated - Currently in Shortage)
- Cytarabine Injection (Updated - Currently in Shortage)
- Megestrol Acetate Suspension (New - Discontinuation)
November 30, 2021
- Drugs@FDA Data Files (updated)
- FDA Drug Shortages
- Amphetamine Oral Suspension, Extended Release (New - Currently in Shortage)
- Betamethasone Valerate Topical Foam (New - Discontinuation)
- Clonidine Hydrochloride Extended Release Tablets (New - Discontinuation)
- Febuxostat Tablets (New - Discontinuation)
- Sterile Water for Injection (New - Currently in Shortage)
- Generic Drug Research Priorities & Projects (updated)